Stock listing

Lang & Schwarz:A41BED Alligator Bioscience AB Aktie

German listing (Lang & Schwarz) of Alligator Bioscience AB · home listing Stockholm:ATORX

Follow Alligator Bioscience AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:ATORX

0.01 SEK -0.00 (-4.7%)

Close on Oct 23, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:ATORX

Past year -96.3% · daily closes, Oct 23, 2025 – Oct 23, 2026, adjusted for splits
Day range
0.0096 – 0.011 SEKOct 23, 2026
Volume
123.0M sharesOct 23, 2026
Market cap
36.04M SEKAt the close on Oct 23, 2026 · price × 3.57B shares outstanding
52-week range
0.0096 – 0.573 SEKLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Alligator Bioscience AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ATORX · Home0.01 SEK-0.001 (-4.7%)122,973,6350.0110.0110.00960.011Close on Oct 23, 2026
Frankfurt:7AL0€0.0001 EUR0.0000 (0.0%)—€0.0001€0.0001€0.0001€0.0001Close on Oct 23, 2026

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OMXSTO:ATORX · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.01-0.001-4.7%0.0110.0110.0096122,973,635
0.0110.00-1.9%0.0110.0110.009963,474,371
0.011-0.001-6.9%0.0120.0130.01132,693,949
0.012-0.001-7.9%0.0130.0130.01144,026,390
0.013-0.001-4.5%0.0130.0130.0136,815,229
0.013+0.00+1.5%0.0130.0130.01322,150,075
0.0130.00-3.0%0.0140.0140.01312,509,086
0.013-0.001-8.8%0.0150.0150.01375,997,507
0.015+0.00+1.4%0.0150.0220.01592,561,964
0.015-0.001-5.2%0.0160.0160.01511,712,187
0.015-0.001-5.0%0.0160.0160.01510,382,603
0.016-0.001-6.9%0.0170.0170.01529,633,664
0.017+0.00+0.6%0.0180.0180.01610,196,727
0.017-0.001-4.4%0.0190.0190.0175,124,857
0.018-0.001-6.7%0.020.0210.01815,525,797
0.0190.00-2.0%0.0210.0210.0191,612,698
0.020.00-1.5%0.020.020.0193,543,122
0.02-0.001-4.3%0.0210.0220.01916,005,292
0.021-0.001-5.4%0.0230.0230.024,916,576
0.022-0.001-3.9%0.0230.0250.02215,111,387
0.023+0.003+16.2%0.020.0250.0235,046,932
0.020.00-2.0%0.0210.0210.022,657,451
0.02-0.001-4.7%0.0210.0210.027,350,637
0.021+0.00+1.0%0.0210.0220.024,516,403
0.021-0.002-8.7%0.0230.0230.0218,977,716
0.023-0.001-2.5%0.0240.0240.0218,263,185
0.024+0.00+1.3%0.0240.0250.0233,163,888
0.023+0.001+4.0%0.0220.0240.02110,361,355
0.022+0.001+4.2%0.0220.0230.02110,024,366
0.022-0.001-5.7%0.0230.0240.0214,188,776
0.0230.00-0.9%0.0230.0240.0225,365,387
0.023-0.001-4.2%0.0240.0250.0234,060,089
0.0240.000.0%0.0250.0250.02216,793,301
0.024-0.002-7.7%0.0270.0270.02412,644,828
0.026+0.001+4.0%0.0260.0270.02522,424,924
0.025-0.001-2.7%0.0260.0270.02524,731,673
0.026-0.001-2.7%0.0260.0280.02517,206,620
0.026-0.001-3.3%0.0280.0310.02536,082,633
0.027+0.006+30.1%0.0310.0390.025119,458,977
0.021+0.001+3.0%0.0220.0220.0219,663,163
0.02-0.001-6.3%0.0210.0220.0224,791,624
0.022-0.002-7.5%0.0230.0240.0230,385,982
0.024+0.004+22.3%0.020.0240.0286,470,796
0.019-0.001-6.9%0.0210.0210.01919,413,458
0.0210.00-2.3%0.0210.0210.025,568,657
0.021+0.001+2.6%0.0220.0220.0218,343,929
0.021-0.001-4.4%0.0220.0230.0227,510,582
0.022+0.001+5.7%0.0210.0250.0255,372,990
0.02-0.002-9.4%0.0220.0230.0241,773,587
0.022-0.002-8.8%0.0250.0250.02239,690,895
0.0250.00-0.8%0.0250.0260.02415,055,807
0.0250.00-0.5%0.0250.0260.02514,539,983
0.025-0.001-2.1%0.0260.0260.02511,181,209
0.0260.00-1.1%0.0260.0260.0253,407,003
0.0260.00-1.0%0.0260.0260.02519,448,449
0.026-0.001-5.0%0.0270.0270.02526,018,763
0.027-0.001-4.3%0.0290.0290.02720,422,123
0.0290.00-0.5%0.0290.0290.0289,529,254
0.0290.00-0.9%0.0290.030.02817,536,102
0.0290.000.0%0.0290.030.02710,506,768
0.029+0.001+4.1%0.0280.0330.02839,894,590
0.028-0.001-1.9%0.0280.0290.02715,323,878
0.0280.00-0.9%0.0290.030.02817,704,753
0.029-0.001-3.2%0.030.030.02827,750,026
0.03-0.003-8.2%0.0330.0330.02954,260,618
0.032-0.002-5.6%0.0340.0350.03172,762,956
0.034-0.098-74.0%0.030.0480.022337,482,440
Ticker
Lang & Schwarz:A41BED
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call

    Wed, Aug 26, 2026 · 9:00 AM ET

    Watch Transcript

  • Alligator Bioscience (Stockholm:ATORX) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 7:00 AM ET

    Watch Transcript

  • Alligator Bioscience (Stockholm:ATORX) Q4 2025 Earnings Call

    Thu, Feb 12, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end

Oct 4, 2026

Closed 0.018 (-6.7%) on Oct 5, 2026

Alligator Bioscience carries out a directed issue of warrants to Fenja Capital in connection with the completed rights issue

Sep 29, 2026

Closed 0.021 (-5.4%) on Sep 29, 2026

Alligator Bioscience announces final outcome in rights issue

Sep 22, 2026

Closed 0.02 (-4.7%) on Sep 23, 2026

Alligator Bioscience announces preliminary outcome in rights issue

Sep 21, 2026

Closed 0.021 (-8.7%) on Sep 21, 2026

Alligator Bioscience publishes prospectus in connection with rights issue

Aug 31, 2026

Closed 0.021 (+3.0%) on Aug 31, 2026

Bulletin from the Extraordinary General Meeting in Alligator Bioscience AB

Aug 26, 2026

Closed 0.024 (+22.3%) on Aug 26, 2026

Invitation to Alligator Bioscience's Earnings Call on 26 August 2026

Aug 20, 2026

Closed 0.021 (-4.4%) on Aug 20, 2026

Alligator discontinues independent development of mitazalimab for a strategic refocus on the HLX22 project, announces a rights issue of units of approximately SEK 125.6 million and raises bridge loans

Jul 23, 2026

Closed 0.034 (-74.0%) on Jul 23, 2026

Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer

Jul 2, 2026

Closed 0.118 (+1.9%) on Jul 2, 2026

Alligator Bioscience AB reports financial results for the period 1 January – 31 March 2026 and provides a business update

May 5, 2026

Closed 0.145 (+0.5%) on May 5, 2026

All Alligator Bioscience AB news

Financings

  • Rights offering of units of ordinary shares and warrants series TO 15 and TO 16

    Sep 22, 2026 · US$5.97M

    Closed: SEK 58.8M raised · SEK 0.04 a unit · each unit consists of two ordinary shares, one warrant series TO 15 and one warrant… · APREA Partners AB +1

    Dealers: APREA Partners AB, Vator Securities AB

    Buyers: Roxette Photo S.A. (part of subscription undertakings totaling SEK 2 million); Søren Bregenholt (part of subscription undertakings totaling SEK 2 million); Vator Securities AB (guarantee commitments totaling SEK 56.8 million together with Mangold); Mangold Fondkommission AB (guarantee commitments totaling SEK 56.8 million together with Vator Securities)

    Insiders: Existing shareholders including CEO Søren Bregenholt have entered into subscription undertakings totaling SEK 2 million

    Use of proceeds: Repayment of bridge loans of SEK 19 million

    Announced Jul 23, 2026 · Update Aug 26, 2026 · Update Aug 31, 2026 · Closed Sep 22, 2026

Read by 6ix AI from the company's releases

Decks

Alligator Bioscience AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
36 in the last 12 months · 76 in all · newest Oct 4, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 26, 2026
Decks
17 decks · latest September 2026

Where Alligator Bioscience AB is listed

ListingExchangeCountryCurrency
Stockholm:ATORX · Home listingStockholmSwedenSEK
LSE:0RK9LSEUnited KingdomSEK
LS Exchange:A41BEDLS ExchangeGermanyEUR
Lang & Schwarz:A41BED · This pageLang & SchwarzGermanyEUR
Aquis:ATORXSAquisUnited KingdomSEK
Frankfurt:7AL0FrankfurtGermanyEUR
Aquis:ATORXSAquisUnited KingdomSEK
Stuttgart:7AL0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Alligator Bioscience AB.